Trial · NCT07884331
Buccal Periosteal Inversion Flap vs Buccal Advancement Flap for Acute Oro-Antral Communication Closure
NCT07884331, Not applicable, Not yet recruiting, Medical University of Graz
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Buccal Periosteal Inversion Flap vs Buccal Advancement Flap for Acute Oro-Antral Communication Closure. Trials, record NCT07884331. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07884331
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Buccal Periosteal Inversion Flap vs Buccal Advancement Flap for Acute Oro-Antral Communication Closure
- NCT number
- NCT07884331
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 22 participants, estimated
- Lead sponsor
- Medical University of Graz
- Conditions
- Acute Oroantral Communication
- Interventions
- Buccal Periosteal Inversion Flap, Buccal Advancement Flap
- First posted
- 2026-10-20
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Width of Keratinized Gingiva | Baseline to 3 months after surgery | Change in keratinized gingival width in millimeters between the preoperative baseline assessment and the three-month postoperative assessment. Keratinized gingival width will be measured between the mucogingival junction and the midpoint of the alveolar ridge using digital intraoral scans obtained with a 3Shape TRIOS 6 intraoral scanner and analyzed using 3D Slicer software. |
| Secondary | Successful Closure of the Oro-Antral Communication | 14 days after surgery | Clinical success will be defined as complete closure of the oro-antral communication without persistent communication between the oral cavity and maxillary sinus. The proportion of successfully closed oro-antral communications will be calculated for each study group. |
| Secondary | Postoperative Pain | Day 0 through postoperative day 7 | Participants will record their daily maximum postoperative pain once daily in the afternoon using a visual analog scale from 0 to 10, where 0 represents no pain and 10 represents very severe pain. |
| Secondary | Postoperative Swelling | Day 0 through postoperative day 7 | Participants will record their daily maximum postoperative swelling once daily in the afternoon using a visual analog scale from 0 to 10, where 0 represents no swelling and 10 represents very severe swelling. |
| Secondary | Postoperative bleeding | Day 0 through postoperative day 7 | Participants will record their daily maximum postoperative bleeding once daily in the afternoon using a visual analog scale from 0 to 10, where 0 represents no postoperative bleeding and 10 represents very severe postoperative bleeding. |
| Secondary | Number of Participants with Postoperative Wound dehiscence | 14 days after surgery | Presence or absence of postoperative separation of the sutured buccal and palatal soft tissues will be clinically assessed 14 days after surgery. Participants will be classified as having wound dehiscence if separation of the wound edges is observed. If wound dehiscence is present, its dimensions will additionally be quantified using the intraoral scan. |
| Secondary | Dimensions of Postoperative Wound Dehiscence | 14 days after surgery | Among participants with postoperative wound dehiscence, the maximum dimensions of the separation of the sutured buccal and palatal soft tissues will be measured in milimeters using an intraoral scan 14 days after surgerx. |
| Secondary | Number of Participants with Recurrent or Persistent Oro-Antral Communication | Up to 3 months after surgery | Occurrence of a persistent or recurrent communication between the oral cavity and maxillary sinus during follow-up will be recorded. |
| Secondary | Number of Participants with Postoperative Sinusitis or Infection | 14 days after surgery | Occurrence of clinically diagnosed postoperative maxillary sinusitis or local infection at the follow-up examination after 14 days will be recorded. Clinical signs and symptoms may include facial pain, pressure sensation, purulent nasal discharge, intraoral purulent drainage, fever, or other clinically relevant signs of infection. |
| Secondary | Reoperation rate | 14 days after surgery | Percentage of participants in each study group requiring surgical revision because of insufficient closure of the oro-antral communication. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07884331
GET https://conductscience.org/api/trials/v1/NCT07884331/registered